SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-034199
Filing Date
2022-12-01
Accepted
2022-12-01 17:15:05
Documents
19
Period of Report
2022-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57171
2 ex4-1.htm EX-4.1 188089
3 ex4-2.htm EX-4.2 144028
4 ex4-3.htm EX-4.3 187457
5 ex10-1.htm EX-10.1 101299
6 ex10-2.htm EX-10.2 356265
7 ex10-3.htm EX-10.3 191109
8 ex99-1.htm EX-99.1 14133
  Complete submission text file 0001493152-22-034199.txt   1663900

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ther-20221129.xsd EX-101.SCH 3230
10 XBRL LABEL FILE ther-20221129_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE ther-20221129_pre.xml EX-101.PRE 22361
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3280
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-52218 | Film No.: 221439550
SIC: 2834 Pharmaceutical Preparations